Dr Elle Reid and Dr Bryony Elder discuss the presentation of temporomandibular disorders and how they can be treated using botulinum toxin
Temporomandibular disorders (TMD) encompass a group of conditions affecting the temporomandibular joint (TMJ) and surrounding musculature, leading to pain, dysfunction and impaired quality of life for affected individuals.
The diagnosis and management of TMD poses significant challenges for medical professionals due to the complex aetiology and diverse clinical presentations of these disorders. In recent years, botulinum toxin (BoNT) has emerged as a promising therapeutic option for managing TMD, offering targeted relief of symptoms and improving patient outcomes.1,2
TMD encompass musculoskeletal conditions characterised by discomfort and/or impairment in the muscles used for chewing, the TMJ and related structures. This category represents the predominant form of non-tooth-related facial pain, often manifesting as facial pain/ headaches, TMJ discomfort, dental pain, restricted jaw…
